SCORE2 Month 6 to Month 12 Results: 12 Month Outcomes of Treatment Change among Poor Responders at Month 6

Related

• 

  Surgical Case Conference

  Carl C. Awh, MD, FASRS

  Carl D. Regillo, MD

  Mohamed AlBahiti, MBBS, FRCSC

  Mohsin H. Ali, MD

  Nishikant J Borse, MS, FMRF, FASRS

  Jonathan S Chang, MD

  Albert Li, MD, FASRS

  Zofia Anna Nawrocka (vel Michalewska), MD, PhD

  Manish Nagpal, MD, FRCS (UK) ,FASRS

  Berna Ozkan, MD

  Uriel Rubin, MD

  Jayanth Sridhar, MD

  Victor M Villegas, MD

  Christina Y Weng, MD, MBA, FASRS

  Annual Meeting Talks

  2018

• 

  The Cilioretinal Artery is Protective Against Choroidal Neovascularization in Age-Related Macular Degeneration

  Glenn C. Yiu, MD, PhD

  Annual Meeting Talks

  2018

• 

  Randomized, Prospective, Double-Masked, Controlled Phase 2b Trial to Evaluate the Safety and Efficacy of ALG-1001 (Luminate®) in Diabetic Macular Edema

  Peter K. Kaiser, MD FASRS

  Annual Meeting Talks

  2018